首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Journal Of Thoracic Oncology

Journal Of Thoracic Oncology杂志,由International Association for the Study of Lung Cancer出版,于2006年创刊,Monthly,出版语言English,ISSN:1556-0864,E-ISSN:1556-1380。

投稿咨询
Journal Of Thoracic Oncology
Journal Of Thoracic Oncology
Journal Of Thoracic Oncology
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
1区
影响因子
23.3
CiteScore
33.4
期刊收录
SCI、SCIE

Journal Of Thoracic Oncology(中文译名:《胸部肿瘤学杂志》),ISSN:1556-0864,EISSN:1556-1380,是International Association for the Study of Lung Cancer出版的国际性学术期刊,创刊于2006年,以Monthly形式稳定发行,2026年总发文量约108篇。该刊采用非OA开放访问,学科归属为医学 - 呼吸系统。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达23.3,2025年期刊CiteScore为33.4,2025年期刊自引率约4.3%,在中科院期刊分区体系中位列医学大类1区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Journal Of Thoracic Oncology长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期一般,3-6周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USACHINA MAINLAND、Japan、Canada、England、Spain、Italy等为核心发文国家与地区;UNIVERSITY OF TEXAS SYSTEMHARVARD UNIVERSITY、MEMORIAL SLOAN KETTERING CANCER CENTER、UNIVERSITY OF TORONTO、UNIVERSITY OF CALIFORNIA SYSTEM、UNICANCER、SHANGHAI JIAO TONG UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
ONCOLOGY 肿瘤学 RESPIRATORY SYSTEM 呼吸系统
1区 1区
是 否

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
ONCOLOGY 肿瘤学 RESPIRATORY SYSTEM 呼吸系统
1区 1区
是 否

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
ONCOLOGY 肿瘤学 RESPIRATORY SYSTEM 呼吸系统
1区 1区
是 否

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 15 / 333

95.6

学科:RESPIRATORY SYSTEM SCIE Q1 3 / 107

97.7

学科:ONCOLOGY SCIE Q1 13 / 333

96.25

学科:RESPIRATORY SYSTEM SCIE Q1 4 / 107

96.73

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q1 13 / 328

96.2

学科:RESPIRATORY SYSTEM SCIE Q1 3 / 108

97.7

学科:ONCOLOGY SCIE Q1 13 / 328

96.19

学科:RESPIRATORY SYSTEM SCIE Q1 4 / 108

96.76


中国学者近期发文

1
Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact (vol 21, pg 41, 2026

Author:Carbone, Michele; Amos, Christopher; Attanoos, Richard L.; Boeri, Mattia; Bueno, Raphael; Bunn, Paul A.; Chirieac, Lucian R.; Cooper, Benjamin; Fennell, Dean; Galateau-Salle, Francoise; Giannakou, Lydia; Goparaju, Chandra, V; Hassan, Raffit; Hofman, Paul; Kris, Mark G.; Mao, Weimin; Minaai, Michael; Mitsudomi, Tsetsuya; Molina, Thierry J.; Montuenga, Luis M.; Nabeshima, Kazuki; Passaro, Antonio; Peters, Solange; Rajan, Arun; Richardson, David B.; Robbins, Hilary; Rolfo, Christian; Rudin, Charles M.; Samet, Jonathan M.; Scherpereel, Arnaud; Schrump, David S.; Sozzi, Gabriella; Taioli, Emanuela; Visona, Silvia D.; Yang, Haining; Yoshikawa, Yoshie; Zhao, An; Pass, Harvey I

Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 4, pp. -. DOI: 10.1016/j.jtho.2026.103576

2
GSTA1 Conferred Tolerance to Osimertinib and Provided Strategies to Overcome Drug-Tolerant Persister in EGFR-Mutant Lung Adenocarcinom

Author:Zhang, Xiaoshen; Wen, Yaokai; Wu, Fengying; Jiang, Yu; Lin, Yuechun; Wang, Lei; Zhou, Fei; Shen, Yue; Min, Zhen; Li, Wei; Liang, Wenhua; He, Jianxing; Zhou, Caicun

Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 3, pp. -. DOI: 10.1016/j.jtho.2025.10.001

3
Neoadjuvant Immunochemotherapy in Resectable NSCLC With SMARCA4 Alteration

Author:Peng, Li-Shan; Cui, Qian; Zhang, Chao; Lin, Jun-Tao; Wu, You; Kang, Jin; Xu, Zi-Yi; Wang, Xiang-Yang; Cao, Ying-Jiao; Zhang, Qing-Ling; Wu, Yi-Long; Hu, Zheng; Zhong, Wen-Zhao

Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 3, pp. -. DOI: 10.1016/j.jtho.2025.10.013

4
Andamertinib in Advanced NSCLC With EGFR Exon 20 Insertions After Platinum-Based Chemotherapy or Immunotherapy: Results From the Phase 2 KANNON Stud

Author:Yang, Jin-Ji; Mu, Yu; Wang, Zhe-Hai; Duan, Jian-Chun; Zhang, Yan; Wu, Lin; Zhong, Hua; Zhao, Jun; Yao, Yu; Wang, Ping; Li, Xiao-Ling; Yang, Run-Xiang; Min, Xu-Hong; Lv, Dong-Qing; Xu, Hai-Peng; Fu, Zhen-Ming; Shen, Bo; Sun, Long-Hua; Wang, Chang-Li; Zhou, Jian-Ya; Xu, Rui-Lian; Ma, Hui-Wen; Zhao, Yan-Qiu; Shi, He-Peng; Zhang, Pei-Long; Xue, Wei-Zhe; Han, Di; Zheng, Yi; Wu, Yi-Long

Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 3, pp. -. DOI: 10.1016/j.jtho.2025.11.008

5
Radiotherapy for Unresectable Locally Advanced NSCLC: A Practical Multidisciplinary Approach to Challenging Scenarios From the International Association for the Study of Lung Cancer Advanced Radiation Technology Subcommitte

Author:Zhu, Hongcheng; Al Saifi, Said; Bahig, Houda; Cooper, Alissa; Abrao, Fernando Conrado; Corrales, Luis; Faivre-Finn, Corinne; Filippi, Andrea Riccardo; Fitzgerald, Bailey; Khosla, Divya; Lam, Vincent K.; Le, Xiuning; Menezes, Vanessa; Newsom-Davis, Tom; Qin, Angel; Putora, Paul Martin; Munoz-Schuffenegger, Pablo; Siva, Shankar; Yu, Nathan Y.; Louie, Alexander, V

Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 3, pp. -. DOI: 10.1016/j.jtho.2025.11.006

6
Response to Letter to the Editor: Refining Immunochemoradiotherapy for Patients With NSCLC and Brain Metastases: Insights on Biomarkers, Neuroprotection, and Global Applicabilit

Author:Li, Yang-Si; Yang, Jin-Ji; Wu, Yi-Long

Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 2, pp. 335-336. DOI: 10.1016/j.jtho.2025.08.023

7
A Game-Changing 20 Years: Progress and Future Directions in Lung Cancer Screenin

Author:Lam, Stephen; Baldwin, David R.; Devaraj, Anand; Field, John; Henschke, Claudia I.; Heuvelmans, Marjolein A.; Huber, Rudolf M.; Jones, Catherine; Borondy-Kitts, Andrea; Li, Molly Siu Ching; Myers, Renelle; Osarogiagbon, Raymond U.; Robbins, Hilary A.; Tammemagi, Martin C.; Taylor, Kathryn L.; Triphuridet, Natthaya; Williams, Randi M.; Yankelevitz, David

Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 2, pp. 235-252. DOI: 10.1016/j.jtho.2025.11.017

8
A Grading System for Resected Invasive Squamous Cell Carcinoma of the Lung: A Multi-Institutional Study by the IASLC Pathology Committe

Author:Mino-Kenudson, Mari; Berezowska, Sabina; Minami, Yuko; Chen, Shuyan; Ray, Meredith A.; Rerkpichaisuth, Vilasinee; Hashisako, Mikiko; Losmanova, Tereza; Hayashi, Takuo; Shim, Hyo-Sup; Righi, Luisella; Gagne, Andreanne; Kim, Tae-Jung; Bubendorf, Lukas; Lopez-Rios, Fernando; Matsubara, Daiske; Von Der Thusen, Jan; Lantuejoul, Sylvie; Roden, Anja C.; Nicholson, Andrew; Jain, Deepali; Han, Yuchen; Wynes, Murry W.; Dacic, Sanja; Smeltzer, Mathew P.; Cooper, Wendy A.; Papotti, Mauro G

Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 2, pp. 294-309. DOI: 10.1016/j.jtho.2025.09.1761

9
The International Association for the Study of Lung Cancer Staging Project: The Impact of Common Molecular Alterations on Overall Survival in NSCLC in Initial Analyses of the IASLC Ninth Edition Staging Database (vol 20, pg 1423, 2025

Author:Carbone, David P.; Hirsch, Fred R.; Osarogiagbon, Raymond Uyiosa; Nishimura, Katherine K.; Tsao, Ming Sound; Travis, William D.; Yang, Dawei; Yang, Soo-Ryum; Yatabe, Yasushi; Araujo, Luiz Henrique; Detterbeck, Frank; Lechtenberg, Kendra J.; Lim, Eric; Mack, Philip C.; Matilla, Jose-Maria; Montuenga, Luis M.; Nicholson, Andrew G.; Suda, Kenichi; Terra, Ricardo M.; Rami-Porta, Ramon; Asamura, Hisao; Rusch, Valerie; Wynes, Murry W

Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 2, pp. 342-342. DOI:

10
Fine Particulate Matter (PM2.5) as a Driver of Genomic Alterations and Lung Tumour Initiatio

Author:Wang, P.; Naso, J.; Myers, R.; Durney, C. H.; Bartolomeu, C.; Mcguire, A.; Macaulay, C.; Lam, S.; Lam, W. L.; Lockwood, W. W

Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 1, pp. -. DOI:


在线咨询

Journal Of Thoracic Oncology

国际简称:J THORAC ONCOL参考译名:胸部肿瘤学杂志

年发文量:108 CiteScore:33.4 是否预警:否 Gold OA文章占比:27.60% 研究类文章占比:93.52%

杂志社联系方式:LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621

Journal Of Thoracic Oncology